Great Point Partners’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,978
Closed -$831K 38
2023
Q1
$831K Buy
+1,978
New +$831K 0.16% 40